Document is current
Any future updates will be listed below
-
Authors
Riaz, Irbaz B.
Humayun, Muhammad Abdullah
Khaki, Ali Raza
Hussain, Syed A. https://orcid.org/0000-0003-1552-511X
- License Information
-
More Information
Article History
Received: 2 September 2025
Accepted: 3 December 2025
First Online: 19 January 2026
Declarations
:
: Irbaz B. Riaz and Muhammad Abdullah Humayun have no conflicts of interest that are directly relevant to the content of this article. Ali Raza Khaki has received research funding to his institution from 23 and Me, Acrivon Therapeutics, Janssen, and Pfizer. Syed A. Hussain has received research funding from CR UK, MRC/NIHR, UHB charities, CCC charities, Northwest Cancer Research, Yorkshire Cancer Research, Weston Park Cancer Charity, Bayer, Janssen, Boehringer Ingelheim, Pierre Fabre, Eli Lilly, and Roche and was on the advisory board or a consultant for Roche, MSD, AstraZeneca, BMS, Janssen, GSK, Astellas, Pfizer, Bayer, Merck, and Boehringer Ingelheim.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: MAH: manuscript writing, figure, tables. SAH: manuscript writing, figure, tables. IBR: manuscript writing, figure, tables. ARK: manuscript writing, figure, tables. All authors have read the final manuscript and agree to be accountable for the work.
